Welcome to the Fall 2024 Notable New Drugs Report
New treatments target relatively small, hard-to-treat patient populations with big drug spend.
This edition of the report showcases:
- A first-in-class treatment for both A and B hemophilia which can reduce the frequency of bleeding episodes.
- A new addition to standard breast cancer therapy with improved outcomes for people with HR-positive breast cancer.
- A new drug to treat a rare congenital heart disease can reduce the risk of death by 57%.
Related healthcare insights
Guide
New treatments for NASH, schizophrenia and more are on the way.
Article
See which trends to consider when assessing the pharmacy benefit, which new drugs may be flying under the radar and what's coming.